Trial Profile
A Multicenter, Double-Blind, Randomized, Vehicle-Controlled Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 Gel in Subjects With Plaque Psoriasis
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 29 Dec 2018
At a glance
- Drugs ESR-114 (Primary)
- Indications Plaque psoriasis
- Focus Proof of concept; Therapeutic Use
- Sponsors Escalier Biosciences
- 22 Aug 2018 New trial record
- 13 Aug 2018 According to a media release, the first patient has been dosed in this study. Top-line data from the study is expected in the first half of 2019.